BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 22042226)

  • 1. Feeling severely affected by multiple sclerosis: what does this mean?
    Strupp J; Hartwig A; Golla H; Galushko M; Pfaff H; Voltz R
    Palliat Med; 2012 Dec; 26(8):1001-10. PubMed ID: 22042226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severely Affected by Parkinson Disease: The Patient's View and Implications for Palliative Care.
    Strupp J; Kunde A; Galushko M; Voltz R; Golla H
    Am J Hosp Palliat Care; 2018 Apr; 35(4):579-585. PubMed ID: 28743187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-rating makes the difference: identifying palliative care needs of patients feeling severely affected by multiple sclerosis.
    Strupp J; Golla H; Galushko M; Buecken R; Ernstmann N; Hahn M; Pfaff H; Voltz R
    Palliat Support Care; 2015 Jun; 13(3):733-40. PubMed ID: 24849300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The psychosocial and cognitive impact of longstanding 'benign' multiple sclerosis.
    Sayao AL; Bueno AM; Devonshire V; Tremlett H;
    Mult Scler; 2011 Nov; 17(11):1375-83. PubMed ID: 21677023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palliative care in patients with severe multiple sclerosis: two case reports and a survey among German MS neurologists.
    Kümpfel T; Hoffmann LA; Pöllmann W; Rieckmann P; Zettl UK; Kühnbach R; Borasio GD; Voltz R
    Palliat Med; 2007 Mar; 21(2):109-14. PubMed ID: 17344259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costs and quality of life of multiple sclerosis in Austria.
    Kobelt G; Berg J; Lindgren P; Plesnilla C; Baumhackl U; Berger T; Kolleger H; Vass K
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S14-23. PubMed ID: 17310339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-cultural adaptation and validation of multiple sclerosis quality of life questionnaire (MSQOL-54) in a Turkish multiple sclerosis sample.
    Idiman E; Uzunel F; Ozakbas S; Yozbatiran N; Oguz M; Callioglu B; Gokce N; Bahar Z
    J Neurol Sci; 2006 Jan; 240(1-2):77-80. PubMed ID: 16277993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costs and quality of life of multiple sclerosis in Switzerland.
    Kobelt G; Berg J; Lindgren P; Gerfin A; Lutz J
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S86-95. PubMed ID: 17310338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Social anxiety in a multiple sclerosis clinic population.
    Poder K; Ghatavi K; Fisk JD; Campbell TL; Kisely S; Sarty I; Stadnyk K; Bhan V
    Mult Scler; 2009 Mar; 15(3):393-8. PubMed ID: 19028833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of quality of life among patients with multiple sclerosis: an Italian cross-sectional study.
    Patti F; Russo P; Pappalardo A; Macchia F; Civalleri L; Paolillo A;
    J Neurol Sci; 2007 Jan; 252(2):121-9. PubMed ID: 17188301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of multiple sclerosis condition-specific measures to inform health policy decision-making: mapping from the MSWS-12 to the EQ-5D.
    Hawton A; Green C; Telford CJ; Wright DE; Zajicek JP
    Mult Scler; 2012 Jun; 18(6):853-61. PubMed ID: 22108867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costs and quality of life of multiple sclerosis in Germany.
    Kobelt G; Berg J; Lindgren P; Elias WG; Flachenecker P; Freidel M; König N; Limmroth V; Straube E
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S34-44. PubMed ID: 17310337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sunlight exposure and sun sensitivity associated with disability progression in multiple sclerosis.
    D'hooghe MB; Haentjens P; Nagels G; Garmyn M; De Keyser J
    Mult Scler; 2012 Apr; 18(4):451-9. PubMed ID: 21952096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing quality of life in multiple sclerosis patients: disability, depressive mood, fatigue and sleep quality.
    Lobentanz IS; Asenbaum S; Vass K; Sauter C; Klösch G; Kollegger H; Kristoferitsch W; Zeitlhofer J
    Acta Neurol Scand; 2004 Jul; 110(1):6-13. PubMed ID: 15180801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurological disability, psychological distress, and health-related quality of life in MS patients within the first three years after diagnosis.
    Kern S; Schrempf W; Schneider H; Schultheiss T; Reichmann H; Ziemssen T
    Mult Scler; 2009 Jun; 15(6):752-8. PubMed ID: 19482864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A primary care-based needs assessment of people with multiple sclerosis.
    MacLurg K; Reilly P; Hawkins S; Gray O; Evason E; Whittington D
    Br J Gen Pract; 2005 May; 55(514):378-83. PubMed ID: 15904557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costs and quality of life of multiple sclerosis in Spain.
    Kobelt G; Berg J; Lindgren P; Izquierdo G; Sánchez-Soliño O; Pérez-Miranda J; Casado MA;
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S65-74. PubMed ID: 17310340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relapses and progression of disability in multiple sclerosis.
    Confavreux C; Vukusic S; Moreau T; Adeleine P
    N Engl J Med; 2000 Nov; 343(20):1430-8. PubMed ID: 11078767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costs and quality of life of multiple sclerosis in Italy.
    Kobelt G; Berg J; Lindgren P; Battaglia M; Lucioni C; Uccelli A
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S45-54. PubMed ID: 17310336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costs and quality of life in multiple sclerosis in The Netherlands.
    Kobelt G; Berg J; Lindgren P; Anten B; Ekman M; Jongen PJ; Polman C; Uitdehaag B
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S55-64. PubMed ID: 17310343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.